Your browser doesn't support javascript.
loading
A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group.
Hong, Huangming; Li, Yexiong; Lim, Soon Thye; Liang, Chaoyong; Huang, He; Yi, Pingyong; Wu, Tao; Du, Xin; Zhang, Mingzhi; Wang, Jinghua; Zhu, Jun; Liu, Ting; Meng, Fanyi; Wu, Gang; Guo, Ye; Zhu, Yuan; Zhao, Weili; Jin, Jie; Li, Juan; Deng, Yanming; Gu, Kangsheng; Wu, Xiangyuan; Ke, Xiaoyan; Xie, Derong; Lin, Daren; Peng, Zhigang; Wu, Junxin; Liu, Qing; Kim, Won Seog; Lin, Tongyu.
Affiliation
  • Hong H; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, and Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Li Y; Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Lim ST; Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Liang C; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Huang H; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
  • Yi P; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, and Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Wu T; Department of Medical Oncology, Hunan Cancer Hospital, Changsha, China.
  • Du X; Department of Lymphoma-Oncology, Guizhou Cancer Hospital, Guiyang, Guizhou, China.
  • Zhang M; Department of Hematology, Guangdong General Hospital, Guangzhou, China.
  • Wang J; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhu J; Department of Medical Oncology, Nanjing General Hospital of Nanjing Military Command, Nanjing, China.
  • Liu T; Department of Lymphoma-Oncology, Peking University Cancer Hospital, Beijing, China.
  • Meng F; Department of Hematology, West China Hospital of Sichuan University, Chengdu, China.
  • Wu G; Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China.
  • Guo Y; Department of Radiation Oncology, Wuhan Union Hospital, Wuhan, China.
  • Zhu Y; Department of Medical Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
  • Zhao W; Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Jin J; Department of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li J; Department of Hematology, the First Affiliated Hospital Zhejiang University, Hangzhou, China.
  • Deng Y; Department of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Gu K; Department of Medical Oncology, the First People's Hospital of Foshan, Foshan, China.
  • Wu X; Department of Medical Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Ke X; Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Xie D; Department of Hematology, Peking University Third Hospital, Beijing, China.
  • Lin D; Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Peng Z; Department of Medical Oncology, Jiangmen Central Hospital, Jiangmen, China.
  • Wu J; Department of Medical Oncology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Liu Q; Department of Radiation Oncology, Fujian Provincial Cancer Hospital, Fuzhou, Fujian, China.
  • Kim WS; Department of Epidemiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Lin T; Division of Hematology Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Leukemia ; 34(8): 2243-2248, 2020 08.
Article in En | MEDLINE | ID: mdl-32066865

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Extranodal NK-T-Cell Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Extranodal NK-T-Cell Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: China
...